Cargando…

Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure

Detalles Bibliográficos
Autores principales:	Morris, I.S., Taylor, H., Fleet, D., Y Lai, F., Charlton, M., Tang, J.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837222/ https://www.ncbi.nlm.nih.gov/pubmed/36717294 http://dx.doi.org/10.1016/j.pulmoe.2023.01.001

Ejemplares similares

Alarming of Severe Respiratory Failure Requiring ECMO Caused by the SARS-CoV-2 Omicron Variant
por: Ohshimo, Shinichiro, et al.
Publicado: (2022)

Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO – A single-centre, retrospective observational cohort experience
por: Charlton, Matthew, et al.
Publicado: (2021)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome
por: Garcia, Bruno, et al.
Publicado: (2020)

Putting a balance on the aerosolization debate around SARS-CoV-2
por: Dancer, S.J., et al.
Publicado: (2020)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
por: Byard, Roger W., et al.
Publicado: (2020)

Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure
por: Masotti, Luca, et al.
Publicado: (2022)

Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone()
por: Feria, Lucia, et al.
Publicado: (2022)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
por: Yano, H., et al.
Publicado: (2020)

Characteristics of Pleural Effusion in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pneumonia
por: Chong, Woon H., et al.
Publicado: (2021)

Iodine mouthwashes as deterrents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Blasi, Claudio
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?
por: Rai, Nitin, et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection
por: Nayagam, Jeremy S, et al.
Publicado: (2021)

The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy
por: Cekic, Sukru, et al.
Publicado: (2021)

Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022)

Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
por: Castillo, P.R., et al.
Publicado: (2020)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

Transient severe neutropenia in an infant with SARS-CoV-2 infection
por: Irie, Shinji, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant
por: Louis, Guillaume, et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
por: Guisado-Vasco, P., et al.
Publicado: (2021)

Response to the comments received on a case report SARS-CoV-2 viral sepsis with meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2021)

Rates of Coinfection Between SARS-CoV-2 and Other Respiratory Viruses in Korea
por: Kim, Young-gon, et al.
Publicado: (2022)

TNF-α Levels in Respiratory Samples Are Associated with SARS-CoV-2 Infection
por: Pereson, Matias J., et al.
Publicado: (2022)

SARS-CoV-2: Is the liver merely a bystander to severe disease?
por: Bangash, Mansoor N., et al.
Publicado: (2020)

Altered severity of the current SARS-CoV-2 in the Kurdistan region of Iraq
por: Hussein, Safin, et al.
Publicado: (2020)

SARS-CoV-2 Infection in a Child with Severe Congenital Neutropenia
por: Vignesh, Pandiarajan, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure
por: Finazzi, Stefano, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Associated with Rhabdomyolysis and Acute Kidney Injury (AKI)
por: Chong, Woon H., et al.
Publicado: (2020)

Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy
por: Koff, Alan G., et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Contamination of High-touch Surfaces in Field Settings*
por: Gholipour, Sahar, et al.
Publicado: (2020)

SARS-CoV-2–Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease
por: Al-Saud, Bandar, et al.
Publicado: (2021)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pvhlpqo08hlgt65avu1st63kt